Page 12 - Micro Caps News Today

Telson Mining sees its FY2020 sales surge 30% to C$44.4M as mining output ramps up at Campo Morado in Mexico The company also said it received the initial US$2 million from the total US$5 million silver stream agreement with Empress Royalty Corp for its Tahuehueto project in Mexico Results were boosted by a nearly 2% average month-over-month rise in zinc prices as well as a more than 4% month-over-month increase in the price of silver during the year Telson Mining Corporation (...

NA Proactive news snapshot: Zynerba Pharmaceuticals, Nerds On Site, Marvel Discovery, Water Tower Research UPDATE … A glance at some of the days highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE), the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders, is presenting two posters at the Society of Biological Psyc...

Namaste Technologies 1Q revenue rises to C$5.5M as cannabis sales surge 113% Namaste said its net cash used in operating activities fell by $7.5 million to $2.5 million, which it attributed to improved management of its short-term assets Namaste recorded the second highest percentage for cannabis revenue out of total net revenue achieved in the last four quarters Namaste Technologies Inc (CVE:N) (OTCMKTS:NXTTF) (FRA:M5BQ) reported a year-over-year increase in its 1Q 2021 net revenu...

Valens applies for Nasdaq listing in the US The company plans to ask its shareholders to approve a consolidation at its annual and special meeting next month The Valens Company is a British Columbia-based producer of cannabis products, medical and recreational The Valens Company Inc (TSE:VLNS) (OTCQX:VLNCF) (FRA:7LV), a producer of cannabis products, announced that it has submitted an initial application to list its common shares on the Nasdaq.  "We have taken a significant step fo...

The European trial will evaluate inhaled QIXLEEF, a THC and CBD drug product, compared to morphine sulfate immediate release to treat breakthrough...

Marrone Bio CEO Kevin Helash ups full-year revenue projections, touts strong spring growing season in shareholder letter The company said it is seeing market signals that support greater demand for its seed treatments, including that corn and soybean prices are at their highest levels since the spring of 2014 Marrone plans to release an independent study of its leading seed treatment product shortly, an analysis of which showed that the product reduces greenhouse gas emissions in s...

Silver co-founded International Royalty Corporation, which was later sold to Royal Gold Inc for C$749 million He has created, purchased and sold more than 150 royalties and streams in the past 15 years Metalla Royalty & Streaming Ltd (CVE:MTA) (NYSEAMERICAN:MTA) (FRA:X9C) said it has appointed Douglas Silver to its board as an independent director effective immediately.     Silver co-founded International Royalty Corporation, which he helped build into the worlds fourth-larges...

Valens to buy US CBD product producer Green Roads in US$40M cash and stock deal The move provides Valens with immediate entry into the US market with a leading CBD health and wellness brand that has an established manufacturing and distribution platform Green Roads, based in south Florida, is the largest privately owned CBD company in the US The Valens Company Inc (TSX:VLNS) (OTCQX:VLNCF) said it has reached a definitive agreement to acquire CBD company Green Roads and its majorit...

NA Proactive news snapshot: PsyBio Therapeutics, Numinus Wellness, Arizona Silver Exploration, Loop Insights, Canada Silver Cobalt Works … A glance at some of the days highlights from the Proactive Investors US and Canada newswires Your daily round-up from the world of Proactive PsyBio Therapeutics Corp (CVE:PSYB) (FRA:PSYB) announced that it has amended its master-sponsored agreement with Miami University based in Oxford, Ohio for the continued advancement of its neuropsychiatr...

CytoDyn raises another $25M for Vyrologix development in second covertable debt offering this month The note may be converted at the option of the investor into shares of the common stock at a price of $10 per share It has raised more than $50 million in the past three weeks and roughly $500 million in the company’s history CytoDyn Inc (OTCQB:CYDY) announced that it has completed an additional potentially non-dilutive convertible debt offering with an institutional investor, which...